Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Reply to comment on "Paediatric sinusitis complicated with subperiosteal abscess and severe proptosis necessitates surgical drainage".

Pediatrics and neonatology·2026

Same journal

Acute encephalopathy with extensive white matter injury associated with severe enteropathy and markedly elevated fecal calprotectin levels in an infant.

Pediatrics and neonatology·2026

Same journal

Post-acute sequelae of COVID in children: Pulmonary assessment using impulse oscillometry and the effect of vaccination.

Pediatrics and neonatology·2026

Same journal

Spleen-tonifying formula alleviates social deficits, gut dysbiosis, and hypomyelination in a perinatal injury model.

Pediatrics and neonatology·2026

Same journal

Editorial to "Risk factors for neonatal abstinence syndrome in infants born to mothers using psychotropic medications: A cohort study".

Pediatrics and neonatology·2026

Same journal

Validation of the postnatal growth and retinopathy of prematurity criteria in Taiwanese: A prospective cohort study.

Pediatrics and neonatology·2026

Search research articles

Related Experiment Videos

Pneumococcal osteomyelitis: report of one case.

W Luke Huang¹, Tse-Ming Wuz, Chin-Kung Yu

¹Department of Pediatrics, Mennonite Christian Hospital, Hualien, Taiwan.

Pediatrics and Neonatology

|January 27, 2009

Summary

Acute osteomyelitis is rare in children, especially when caused by Streptococcus pneumoniae. This case highlights successful treatment of penicillin-resistant Streptococcus pneumoniae osteomyelitis in an infant using vancomycin and clindamycin.

Related Experiment Videos

Area of Science:

Pediatric infectious diseases
Bacterial osteomyelitis
Pharmacology

Background:

Acute osteomyelitis affects approximately 1 in 5,000 children under 13.
Streptococcus pneumoniae accounts for only 1.3% of pediatric acute osteomyelitis cases.
Penicillin-resistant strains present unique treatment challenges.

Observation:

A 7-month-old male infant presented with acute osteomyelitis.
The infection was caused by penicillin-resistant Streptococcus pneumoniae.
The infant had no significant past medical history.

Findings:

Successful treatment was achieved with intravenous vancomycin.
Oral clindamycin was used as a secondary agent.
The infant recovered without complications.

Implications:

This case demonstrates effective therapeutic options for rare pediatric bacterial bone infections.
Vancomycin and clindamycin can be considered for penicillin-resistant Streptococcus pneumoniae osteomyelitis.
Highlights the importance of susceptibility testing in pediatric osteomyelitis management.